PNC FINANCIAL SERVICES GROUP, INC. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$113,456
-18.0%
2,467
+2.5%
0.00%
Q2 2023$138,389
+61.9%
2,408
+5.6%
0.00%
Q1 2023$85,502
+28.4%
2,280
-4.0%
0.00%
Q4 2022$66,575
-16.8%
2,376
-17.0%
0.00%
Q3 2022$80,000
+14.3%
2,863
+41.6%
0.00%
Q2 2022$70,000
-4.1%
2,022
+0.2%
0.00%
Q1 2022$73,000
+65.9%
2,017
+4.2%
0.00%
Q4 2021$44,000
+7.3%
1,936
-10.0%
0.00%
Q3 2021$41,000
-12.8%
2,151
-5.9%
0.00%
Q2 2021$47,000
-4.1%
2,287
-16.0%
0.00%
Q1 2021$49,000
+2.1%
2,721
+16.1%
0.00%
Q4 2020$48,000
+20.0%
2,344
+13.1%
0.00%
Q3 2020$40,000
-9.1%
2,073
+5.1%
0.00%
Q2 2020$44,000
+46.7%
1,972
-2.4%
0.00%
Q1 2020$30,000
-42.3%
2,021
-25.8%
0.00%
Q4 2019$52,000
+8.3%
2,725
+13.1%
0.00%
Q3 2019$48,000
-4.0%
2,409
+4.2%
0.00%
Q2 2019$50,000
+11.1%
2,313
+2.3%
0.00%
Q1 2019$45,000
+7.1%
2,262
+3.8%
0.00%
Q4 2018$42,000
+23.5%
2,180
+22.1%
0.00%
Q3 2018$34,000
+161.5%
1,785
+142.9%
0.00%
Q2 2018$13,000
-50.0%
735
-47.5%
0.00%
Q1 2018$26,000
-3.7%
1,399
-1.6%
0.00%
Q4 2017$27,000
+285.7%
1,422
+260.9%
0.00%
Q3 2017$7,000
-99.4%
394
-99.3%
0.00%
-100.0%
Q2 2017$1,082,000
+23.0%
60,521
-0.1%
0.00%0.0%
Q1 2017$880,000
-58.4%
60,611
-47.3%
0.00%
-50.0%
Q4 2016$2,117,000
-4.9%
114,970
-2.1%
0.00%
-33.3%
Q3 2016$2,226,000
+111200.0%
117,392
+112776.9%
0.00%
Q2 2016$2,000
+100.0%
104
-3.7%
0.00%
Q1 2016$1,0000.0%108
+3.8%
0.00%
Q4 2015$1,0000.0%1040.0%0.00%
Q3 2015$1,000
-50.0%
104
+3.0%
0.00%
Q2 2015$2,0001010.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders